Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease

BACKGROUND: Approximately 15–20% of ulcerative colitis patients and 20–40% of those with Crohn’s disease experience extraintestinal manifestations (EIMs) of their inflammatory bowel disease (IBD). Clinicians who treat IBD must manage EIMs affecting multiple organs that variably correlate with intest...

Full description

Saved in:
Bibliographic Details
Published in:Dig Dis Sci
Main Authors: Fleisher, Mark, Marsal, Jan, Lee, Scott D., Frado, Laura E., Parian, Alyssa, Korelitz, Burton I., Feagan, Brian G.
Format: Artigo
Language:Inglês
Published: Springer US 2018
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5854745/
https://ncbi.nlm.nih.gov/pubmed/29484571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-018-4971-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items